يعرض 1 - 10 نتائج من 4,818 نتيجة بحث عن '"ORLISTAT"', وقت الاستعلام: 1.46s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial.

    المؤلفون: Liu, Shuang1 (AUTHOR), Lin, Xiaojing1 (AUTHOR), Tao, Minghao1 (AUTHOR), Chen, Qi1 (AUTHOR), Sun, Hang1 (AUTHOR), Han, Yali2 (AUTHOR), Yang, Shaoling1 (AUTHOR), Gao, Yining3 (AUTHOR), Qu, Shen1,2 (AUTHOR) qushencn@hotmail.com, Chen, Haibing1 (AUTHOR) hbchen@tongji.edu.cn

    المصدر: Lipids in Health & Disease. 3/11/2024, Vol. 23 Issue 1, p1-10. 10p.

    مصطلحات موضوعية: *ORLISTAT, *WEIGHT loss, *OBESITY, *HYPERURICEMIA, *BODY weight, *LASER therapy, *SAFETY

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced Hepatic Damage in Mice.

    المؤلفون: Alamoudi, Jawaher Abdullah1 (AUTHOR) jaalamoudi@pnu.edu.sa, El-Masry, Thanaa A.2 (AUTHOR) thanaa.elmasri@pharm.tanta.edu.eg, Nasr, Mohamed3,4 (AUTHOR) m2naser@yahoo.com, Ibrahim, Ismail T.5,6 (AUTHOR) ismailtaha2018@gmail.com, Ibrahim, Hanaa A.2 (AUTHOR) hanaa.abdelkareem@pharm.tanta.edu.eg, Saad, Hebatallah M.7 (AUTHOR) heba.magdy@mau.edu.eg, El-Nagar, Maysa M. F.2 (AUTHOR) maysa_elnagar@outlook.com, Alshawwa, Samar Zuhair1 (AUTHOR) szalshawwa@pnu.edu.sa, Alrashidi, Amal1 (AUTHOR) aaalrashidi@pnu.edu.sa, El Zahaby, Enas I.3 (AUTHOR) enas.elzahabi@deltauniv.edu.eg

    المصدر: Pharmaceuticals (14248247). Jan2024, Vol. 17 Issue 1, p96. 26p.

    مصطلحات موضوعية: *FATTY acid synthases, *ORLISTAT, *HEMATOXYLIN & eosin staining, *PRECIPITATION (Chemistry), *LIPASE inhibitors

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Effectiveness and persistence of anti-obesity medications (liraglutide 3 mg, lorcaserin, and orlistat) in a real-world primary care setting.

    المؤلفون: Leventhal-Perek, Sharon1,2 (AUTHOR) sharonleventhal@gmail.com, Shani, Michal2,3 (AUTHOR), Schonmann, Yochai1,4,5 (AUTHOR)

    المصدر: Family Practice. Oct-Dec2023, Vol. 40 Issue 5/6, p629-637. 9p.

    مصطلحات موضوعية: *ANTIOBESITY agents, *ORLISTAT, *LIRAGLUTIDE, *WEIGHT loss, *PRIMARY care


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double‐blind randomized crossover pilot trial.

    المؤلفون: Primeaux, Stefany D.1,2 (AUTHOR), Dubin, Robert3 (AUTHOR), Greenway, Frank L.4 (AUTHOR) frank.greenway@pbrc.edu

    المصدر: Diabetes, Obesity & Metabolism. Aug2023, Vol. 25 Issue 8, p2236-2242. 7p.

    مصطلحات موضوعية: *MOUTHWASHES, *ORLISTAT, *CROSSOVER trials, *FAT, *BODY mass index, *TONGUE


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Metformin versus Orlistat for The Management of Infertile Obese Patients with polycystic Ovary Syndrome; A Randomized Controlled Trial.

    المؤلفون: Ali, Mohamad Ramadan, Ali Mohammed, Ibrahem Ahmed, El-beheidy, Tarek Mohamed, Helal, Khaled Fathy

    المصدر: Zagazig University Medical Journal; 2024 Supplement, Vol. 30, p373-384, 12p

    مصطلحات موضوعية: POLYCYSTIC ovary syndrome, RANDOMIZED controlled trials, ORLISTAT, METFORMIN, INFERTILITY, OBESITY, MALE infertility


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Policy Interventions to Enhance Medical Care for People With Obesity in the United States—Challenges, Opportunities, and Future Directions.

    المؤلفون: JOLIN, JAMES RENÉ, KWON, MINSOO, BROCK, ELIZABETH, CHEN, JONATHAN, KOKAN, AISHA, MURDOCK, RYAN, STANFORD, FATIMA CODY

    المصدر: Milbank Quarterly; Jun2024, Vol. 102 Issue 2, p336-350, 15p

    مصطلحات موضوعية: POLICY sciences, GLUCAGON-like peptide-1 agonists, HEALTH services accessibility, BARIATRIC surgery, INSURANCE, TOPIRAMATE, PREJUDICES, HEALTH policy, MEDICAL care, REGULATION of body weight, MEDICARE, BODY weight, NUTRITION counseling, PATIENT advocacy, ORLISTAT, DRUG approval, CONCEPTUAL structures, MEDICATION therapy management, ANTIOBESITY agents, BUPROPION, DISEASE relapse, COGNITIVE therapy, OBESITY, BEHAVIOR therapy, MEDICAL care costs, SOCIAL stigma, NALTREXONE, NUTRITION

    مصطلحات جغرافية: UNITED States

    الشركة/الكيان: UNITED States. Food & Drug Administration


    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the 2023 international evidence‐based guideline.

    المؤلفون: Goldberg, Alyse, Graca, Sandro, Liu, Jing, Rao, Vibhuti, Witchel, Selma Feldman, Pena, Alexia, Li, Rong, Mousa, Aya, Tay, Chau Thien, Pattuwage, Loyal, Teede, Helena, Yildiz, Bulent O., Ee, Carolyn

    المصدر: Obesity Reviews; May2024, Vol. 25 Issue 5, p1-23, 23p

    مصطلحات موضوعية: ANTIOBESITY agents, POLYCYSTIC ovary syndrome, EXENATIDE, SEMAGLUTIDE, ORLISTAT


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial

    المؤلفون: Shuang Liu, Xiaojing Lin, Minghao Tao, Qi Chen, Hang Sun, Yali Han, Shaoling Yang, Yining Gao, Shen Qu, Haibing Chen

    المصدر: Lipids in Health and Disease, Vol 23, Iss 1, Pp 1-10 (2024)

    مصطلحات موضوعية: Hyperuricemia, Orlistat, Uric acid, Gout flare, Nutritional diseases. Deficiency diseases, RC620-627

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1476-511XTest

    الوصول الحر: https://doaj.org/article/befe9935a2064a67accd173d83a7aef1Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Atorvastatin versus tetrahydrolipstatin in male patients with dyslipidemia: A systematic review and meta-analysis

    المؤلفون: Nur Aini Hasan, Viskasari Pintoko Kalanjati, Kusuma Eko Purwantari, Abdurachman Abdurachman, Muhammad Miftahussurur

    المصدر: Journal of Pharmacy & Pharmacognosy Research, Vol 12, Iss 2, Pp 218-230 (2024)

    مصطلحات موضوعية: atorvastatin, dyslipidemia, obesity, orlistat, tetrahydrolipstatin, Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441

    وصف الملف: electronic resource

    العلاقة: https://jppres.com/jppres/pdf/vol12/jppres23.1741_12.2.218.pdfTest; https://doaj.org/toc/0719-4250Test

    الوصول الحر: https://doaj.org/article/b88e1116c46343599774bbe832f89ff5Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Effects of Tetrahydrolipstatin on Glioblastoma in Mice: MRI-Based Morphologic and Texture Analysis Correlated with Histopathology and Immunochemistry Findings—A Pilot Study.

    المؤلفون: Wagner, Sabine, Ewald, Christian, Freitag, Diana, Herrmann, Karl-Heinz, Koch, Arend, Bauer, Johannes, Vogl, Thomas J., Kemmling, André, Gufler, Hubert

    المصدر: Cancers; Apr2024, Vol. 16 Issue 8, p1591, 16p

    مصطلحات موضوعية: GLIOMAS, IMMUNOCHEMISTRY, RECEIVER operating characteristic curves, APOPTOSIS, ANIMALS, CELL proliferation, ORLISTAT, TREATMENT effectiveness, MAGNETIC resonance imaging, DESCRIPTIVE statistics, IN vivo studies, GENE expression, MICE, ANIMAL experimentation, WESTERN immunoblotting, FATTY acids, PHARMACODYNAMICS

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث